Table 1 Demographics and clinical characteristics of the patients at baseline and follow-ups
Demographic and clinical features | Number (percentage) Or Mean ± SD | ||||
|---|---|---|---|---|---|
Baseline (N = 142) | 1 Month (N = 137) | 3 Months (N = 131) | 6 Months (N = 128) | 12 Months (N = 115) | |
Age, years (Mean ± SD) | 63.49 ± 11.07 | 63.47 ± 12.11 | 64.09 ± 18.43 | 62.89 ± 7.31 | 63.66 ± 10.03 |
Gender | |||||
 Male | 69 (48.59%) | 67 (48.91%) | 63 (48.09%) | 62 (48.44%) | 55 (48.59%) |
 Female | 73 (51.41%) | 70 (51.09%) | 68 (51.91%) | 66 (51.56%) | 60 (51.41%) |
Education | |||||
 Primary or lower | 33 (23.24%) | 32 (23.36%) | 30 (22.90%) | 29 (22.66%) | 24 (20.87%) |
 Secondary | 51 (35.92%) | 47 (34.31%) | 45 (34.35%) | 45 (35.16%) | 39 (33.91%) |
 Tertiary or higher | 58 (40.85%) | 58 (42.34%) | 56 (42.75%) | 54 (42.19%) | 52 (45.22%) |
Marital status | |||||
 Married | 98 (69.01%) | 96 (70.07%) | 97 (74.05%) | 95 (74.22%) | 93 (80.87%) |
 Not currently married | 44 (30.99%) | 41 (29.93%) | 34 (25.95%) | 33 (25.78%) | 22 (19.13%) |
Area of residence | |||||
 Urban | 114 (80.28%) | 114 (83.21%) | 109 (83.21%) | 106 (82.81%) | 94 (81.74%) |
 Rural | 28 (19.72%) | 23 (16.79%) | 22 (16.79%) | 22 (17.19%) | 21 (18.26%) |
Income | |||||
  ≥ 10,000RMB/month | 62 (43.66%) | 57 (41.61%) | 56 (42.75%) | 55 (42.97%) | 45 (39.13%) |
 <10,000RMB/month | 80 (56.34%) | 80 (58.39%) | 75 (57.25%) | 73 (57.03%) | 70 (60.87%) |
Eye affected by AMD | |||||
 Unilateral cases | 112 (68.31%) | 109 (79.56%) | 107 (81.68%) | 106 (82.81%) | 93 (80.87%) |
 Bilateral cases | 30 (31.69%) | 28 (20.44%) | 24 (18.32%) | 22 (17.19%) | 22 (19.13%) |
VA treated eye | 0.29 ± 0.03 | 0.32 ± 0.02 | 0.38 ± 0.11 | 0.41 ± 0.18 | 0.40 ± 0.19 |
BCVA | 0.51 ± 0.12 | 0.48 ± 0.03 | 0.58 ± 0.07 | 0.62 ± 0.21 | 0.58 ± 0.16 |
No. of intravitrealinjections |  | 1.02 ± 0.15 | 3.07 ± 0.25 | 3.80 ± 0.76 | 4.70 ± 0.85 |